Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2016, Article ID 6492953, 10 pages
http://dx.doi.org/10.1155/2016/6492953
Research Article

In Vitro and In Vivo Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin

Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar University, Mullana, Ambala, Haryana 133207, India

Received 31 December 2015; Revised 5 April 2016; Accepted 13 April 2016

Academic Editor: Gaio Paradossi

Copyright © 2016 Gyati Shilakari Asthana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Lamprecht, Nanotherapeutics: Drug Delivery Concepts in Nanoscience, Pan Stanford, Singapore, 2009.
  2. C. J. H. Porter and W. N. Charman, “Intestinal lymphatic drug transport: an update,” Advanced Drug Delivery Reviews, vol. 50, no. 1-2, pp. 61–80, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. A. J. Humberstone and W. N. Charman, “Lipid-based vehicles for the oral delivery of poorly water soluble drugs,” Advanced Drug Delivery Reviews, vol. 25, no. 1, pp. 103–128, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. M. L. Shively and D. C. Thompson, “Oral bioavailability of vancomycin solid-state emulsions,” International Journal of Pharmaceutics, vol. 117, no. 1, pp. 119–122, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Bert and G. De Boer, Drug Absorption Enhancement, Howard Academic Publishers, Washington, DC, USA, 1994.
  6. S. P. Kumar, S. Kumar, V. K. Shukla, S. Sarasvat, and R. Chaudhary, “Formulation development and evaluation of clarythromycin oral dosage form against helicobacter pylori infection,” International Research Journal of Pharmacy, vol. 3, no. 4, pp. 281–287, 2012. View at Google Scholar
  7. B. Joshi, G. Singh, A. C. Rana, and S. Seema, “Development and characterization of clarithromycin emulgel for topical delivery,” International Journal of Drug Development and Research, vol. 4, no. 3, pp. 310–323, 2012. View at Google Scholar
  8. R. Thagele, Mishra, and A. K. Pathak, “Formulation and characterization of clarithromycin based nanoparticulate drug delivery system,” International Journal of Pharmacy and Life Sciences, vol. 2, no. 1, pp. 510–515, 2011. View at Google Scholar
  9. L. Hu, W. Liu, L. Li, J. Zhao, and X. Yang, “Preparation and in vitro, in vivo evaluation of clarithromycin microcapsules,” Journal of Basic and Clinical Pharmacy, vol. 2, no. 1, pp. 1–9, 2011. View at Google Scholar
  10. A. Sanjivani, S. Swapnila, D. Shalaka, B. Uddhav, and S. Jagdish, “Development and evaluation of hollow microspheres of clarithromycin as a gastroretentive drug delivery system using eudragit polymers,” International Journal of Pharma and Bio Sciences, vol. 2, no. 3, pp. 344–358, 2011. View at Google Scholar · View at Scopus
  11. C. Sinico, M. Manconia, M. Peppib, F. Lai, D. Valenti, and A. M. Fadda, “Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction,” Journal of Control Release, vol. 103, no. 1, pp. 123–136, 2005. View at Publisher · View at Google Scholar
  12. D. Paolino, D. Cosco, R. Muzzalupo, E. Trapasso, N. Picci, and M. Fresta, “Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer,” International Journal of Pharmaceutics, vol. 353, no. 1-2, pp. 233–242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Dingler, R. P. Blum, H. Niehus, R. H. Müller, and S. Gohla, “Solid lipid nanoparticles (SLN(TM)/Lipopearls(TM))-a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products,” Journal of Microencapsulation, vol. 16, no. 6, pp. 751–767, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. S. K. Patel, T. Chand, and M. Talsania, “Formulation development and evaluation of microspheres containing duloxetine hydrochloride,” International Journal of Research in Pharmaceutical and Biomedical Sciences, vol. 4, no. 2, pp. 568–572, 2013. View at Google Scholar
  15. S. Gopalakrishnan and A. Chenthilnathan, “Niosomes—a novel drug delivery device,” Research Journal of Pharmaceutical, Biological and Chemical Sciences, vol. 3, no. 3, pp. 1090–1098, 2012. View at Google Scholar · View at Scopus
  16. P. K. Sharma, G. S. Asthana, A. Asthana, P. Dang, and D. Singh, “Advances in niosomes based novel vesicular drug delivery systems,” Inventi Rapid: NDDS, vol. 2013, no. 3, pp. 1–11, 2013. View at Google Scholar
  17. G. Shilakari, D. Singh, and A. Asthana, “Novel vesicular carriers for topical drug delivery and their applications,” International Journal of Pharmaceutical Sciences Review and Research, vol. 21, no. 1, pp. 77–86, 2013. View at Google Scholar · View at Scopus
  18. B. W. Barry, “Novel mechanisms and devices to enable successful transdermal drug delivery,” European Journal of Pharmaceutical Sciences, vol. 14, no. 2, pp. 101–114, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. R. M. Handjani-Vila, A. Ribier, B. Rondot, and G. Vanlerberghie, “Dispersions of lamellar phases of non-ionic lipids in cosmetic products,” International Journal of Cosmetic Science, vol. 1, no. 5, pp. 303–314, 1979. View at Publisher · View at Google Scholar · View at Scopus
  20. D. D. Lasic, “The mechanism of vesicle formation,” Biochemical Journal, vol. 256, no. 1, pp. 1–11, 1988. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Arunothayanun, J. A. Turton, I. F. Uchegbu, and A. T. Florence, “Preparation and in vitro in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical tubular niosomes,” Journal of Pharmaceutical Sciences, vol. 88, pp. 34–38, 1999. View at Google Scholar
  22. I. F. Uchegbu, J. A. Double, J. A. Turton, and A. T. Florence, “Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) niosomes in the mouse,” Pharmaceutical Research, vol. 12, no. 7, pp. 1019–1024, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Yoshioka, B. Sternberg, and A. T. Florence, “Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85),” International Journal of Pharmaceutics, vol. 105, no. 1, pp. 1–6, 1994. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Hao, F. Zhao, N. Li, Y. Yang, and K. Li, “Studies on a high encapsulation of colchicine by a niosome system,” International Journal of Pharmaceutics, vol. 244, no. 1-2, pp. 73–80, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. J.-Y. Fang, S.-Y. Yu, P.-C. Wu, Y.-B. Huang, and Y.-H. Tsai, “In vitro skin permeation of estradiol from various proniosome formulations,” International Journal of Pharmaceutics, vol. 215, no. 1-2, pp. 91–99, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Manconi, D. Valenti, C. Sinico, F. Lai, G. Loy, and A. M. Fadda, “Niosomes as carriers for tretinoin: II. Influence of vesicular incorporation on tretinoin photostability,” International Journal of Pharmaceutics, vol. 260, no. 2, pp. 261–272, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Agarwal, O. P. Katare, and S. P. Vyas, “Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol,” International Journal of Pharmaceutics, vol. 228, no. 1-2, pp. 43–52, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. J.-Y. Fang, C.-T. Hong, W.-T. Chiu, and Y.-Y. Wang, “Effect of liposomes and niosomes on skin permeation of enoxacin,” International Journal of Pharmaceutics, vol. 219, no. 1-2, pp. 61–72, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Marianecci, D. Paolino, C. Celia, M. Fresta, M. Carafa, and F. Alhaique, “Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts,” Journal of Controlled Release, vol. 147, no. 1, pp. 127–135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Elhissi, K. Hidayat, D. A. Phoenix et al., “Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology,” International Journal of Pharmaceutics, vol. 444, no. 1-2, pp. 193–199, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Saxena, V. Kapoor, and M. D. Bharti, “Formulation and evaluation of topical niosomal gel of roxithromycin,” World Journal of Pharmaceutical Research, vol. 3, no. 1, pp. 3000–3016, 2014. View at Google Scholar
  32. V. R. Yasam, S. L. Jakki, J. Natarajan et al., “A novel vesicular transdermal delivery of nifedipine-preparation, characterization and in vitro/in-vivo evaluation,” Drug Delivery, vol. 23, no. 2, pp. 629–640, 2014. View at Publisher · View at Google Scholar
  33. S. Moghassemi, A. Hadjizadeh, and K. Omidfar, “Formulation and characterization of bovine serum albumin-loaded niosome,” AAPS Pharmaceutical Science and Technology, 2016. View at Publisher · View at Google Scholar
  34. S. Pawar and P. Vavia, “Glucosamine anchored cancer targeted nano-vesicular drug delivery system of doxorubicin,” Journal of Drug Targeting, vol. 24, no. 1, pp. 68–79, 2016. View at Publisher · View at Google Scholar
  35. P. Balakrishnana, S. Shanmugama, W. S. Leea, W. M. Leea, and J. O. Kim, “Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery,” International Journal of Pharmaceutics, vol. 377, no. 1-2, pp. 1–8, 2009. View at Publisher · View at Google Scholar
  36. B. Mukherjee, B. Patra, B. Layek, and A. Mukherjee, “Sustained release of acyclovir from nano-liposome and nano-niosomes: an in vitro study,” International Journal of Nanomedicine, vol. 2, no. 2, pp. 213–225, 2007. View at Google Scholar
  37. P. U. M. Firthouse, S. M. Halith, S. U. Wahab, M. Sirajudeen, and S. K. Mohideen, “Formulation and evaluation of miconazole niosomes,” International Journal of PharmTech Research, vol. 3, no. 2, pp. 1019–1022, 2011. View at Google Scholar · View at Scopus
  38. A. A. H. Sathali and T. Sangeetha, “Formulation and evaluation of ocular niosomal in situ gel of levofloxacin hemihydrates,” Journal of Pharmacy Research, vol. 4, pp. 4331–4337, 2011. View at Google Scholar
  39. A. A. H. Sathali and G. Rajalakshmi, “Evaluation of transdermal targeted niosomal drug delivery of terbinafine hydrochloride,” International Journal of PharmTech Research, vol. 2, no. 3, pp. 2081–2089, 2010. View at Google Scholar · View at Scopus
  40. G. S. Asthana, A. Asthana, D. V. Kohli, and S. P. Vyas, “Mannosylated chitosan nanoparticles for delivery of antisense oligonucleotides for macrophage targeting,” BioMed Research International, vol. 2014, Article ID 526391, 17 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Wadhwa, A. Asthana, S. Gupta, G. S. Asthana, and R. Singh, “Development and optimization of polymeric self-emulsifying nanocapsules for localized drug delivery: design of experiment approach,” The Scientific World Journal, vol. 2014, Article ID 516069, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. P. S. Jadon, V. Gajbhiye, R. S. Jadon, K. R. Gajbhiye, and N. Ganesh, “Enhanced oral bioavailability of griseofulvin via niosomes,” AAPS PharmSciTech, vol. 10, no. 4, pp. 1186–1192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Sambhakar, B. Singh, S. K. Paliwal, and P. R. Mishra, “Niosomes as a potential carrier for controlled release of cefuroxime axetil,” Asian Journal of Biochemical and Pharmaceutical Research, vol. 1, no. 1, pp. 126–136, 2011. View at Google Scholar
  44. R. Bi and N. Zhang, “Liposomes as a carrier for pulmonary delivery of peptides and proteins,” Journal of Biomedical Nanotechnology, vol. 3, no. 4, pp. 332–341, 2007. View at Publisher · View at Google Scholar · View at Scopus